L1CAM positivity was detected in 71.6% of peripheral blood CTCs, primarily localized to H-CTCs, and served as an independent predictor of lymph node metastasis (OR ≈ 8.37). Here, L1CAM is linked to metastatic malignant neoplasm in the lymph nodes.